[Congenital adrenogenital syndrome].
Knorr
D
D
D015068:17-Ketosteroids / Q000097:blood; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D000328:Adult; D002648:Child; D003534:Cyproterone / Q000008:administration & dosage / Q000031:analogs & derivatives; D017373:Cyproterone Acetate; D003900:Desoxycorticosterone / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005438:Fludrocortisone / Q000008:administration & dosage / Q000031:analogs & derivatives; D006580:Genetic Carrier Screening; D006680:HLA Antigens / Q000235:genetics; D006238:Haploidy; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D007231:Infant, Newborn; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D011247:Pregnancy; D011296:Prenatal Diagnosis
D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D006680:HLA Antigens; D003900:Desoxycorticosterone; D017373:Cyproterone Acetate; D003907:Dexamethasone; D003534:Cyproterone; D005438:Fludrocortisone; C034635:fludrocortisone acetate; D011241:Prednisone; D006854:Hydrocortisone
Das congenitale adrenogenitale Syndrom.